World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
22479
World Ranking
3092
National Ranking
1448

Overview

Stuart C. Ray is affiliated with the Johns Hopkins University School of Medicine in the United States. The primary field of study for this scientist is Medicine, with a particular focus on Infectious Diseases, Epidemiology, Hepatology, Radiology, Nuclear Medicine and Imaging, and Immunology.

The main topics covered in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • Hepatitis B Virus Studies
  • Monoclonal and Polyclonal Antibodies Research
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 detection and testing

Stuart C. Ray's recent publications feature a range of studies primarily relating to COVID-19 and immune responses. Notable papers include:

  • "Durable SARS-CoV-2 B cell immunity after mild or severe disease" (2021, Journal of Clinical Investigation)
  • "Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2" (2020, Journal of Clinical Investigation)
  • "IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function" (2022, JCI Insight)
  • "IgM autoantibodies recognizing ACE2 are associated with severe COVID-19" (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • "Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore-Washington metropolitan area" (2021, JCI Insight)

Frequent publication venues for Stuart C. Ray include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Journal of Clinical Investigation
  • JCI Insight
  • Immunity

The scientist has worked with several frequent co-authors, revealing a collaborative research network. These include:

  • Andrea L. Cox
  • Justin R. Bailey
  • Nicole Skinner
  • Clinton O. Ogega
  • Andrew Pekosz

Best Publications

  • Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination

    Kavita S. Lole;Robert C. Bollinger;Ramesh S. Paranjape;Deepak Gadkari

  • Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

    Robert Thimme;David Oldach;Kyong Mi Chang;Kyong Mi Chang;Carola Steiger

  • Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

    Kui Li;Eileen Foy;Josephine C. Ferreon;Mitsuyasu Nakamura

  • Protection against persistence of hepatitis C.

    Shruti H. Mehta;Andrea Cox;Donald R. Hoover;Xiao Hong Wang

  • Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART

    Richard E. Nettles;Tara L. Kieffer;Tara L. Kieffer;Patty Kwon;Daphne Monie

  • Genetic Epidemiology of Hepatitis C Virus throughout Egypt

    Stuart C. Ray;Ray R. Arthur;Anthony Carella;Jens Bukh

  • Acute hepatitis C

    Anurag Maheshwari;Stuart Ray;Paul J Thuluvath

  • Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells

    Justin R. Bailey;Ahmad R. Sedaghat;Tara Kieffer;Timothy Brennan

  • Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity against Persistent Reinfection

    William O. Osburn;Brian E. Fisher;Kimberly A. Dowd;Giselle Urban

  • Cellular immune selection with hepatitis C virus persistence in humans

    Andrea L. Cox;Timothy Mosbruger;Qing Mao;Zhi Liu

  • Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C

    Ashwin Balagopal;Frances H. Philp;Jacquie Astemborski;Timothy M. Block

  • Prospective Evaluation of Community‐Acquired Acute‐Phase Hepatitis C Virus Infection

    Andrea L. Cox;Dale M. Netski;Timothy Mosbruger;Susan G. Sherman

  • Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

    Andrea L. Cox;Timothy Mosbruger;Georg M. Lauer;Drew Pardoll

  • Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses.

    William O. Osburn;Anna E. Snider;Brittany L. Wells;Rachel Latanich

  • HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy

    Monika Hermankova;Stuart C. Ray;Christian Ruff;Monique Powell-Davis

  • Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus.

    Kimberly A. Dowd;Dale M. Netski;Xiao–Hong Wang;Andrea L. Cox

  • Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy

    Stuart C. Ray;Yu Ming Wang;Oliver Laeyendecker;John R. Ticehurst;John R. Ticehurst

  • Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads.

    Tara L. Kieffer;Mariel M. Finucane;Richard E. Nettles;Thomas C. Quinn;Thomas C. Quinn

  • A stable latent reservoir for HIV-1 in resting CD4+ T lymphocytes in infected children

    Deborah Persaud;Theodore Pierson;Christian Ruff;Diana Finzi

  • G→A Hypermutation in Protease and Reverse Transcriptase Regions of Human Immunodeficiency Virus Type 1 Residing in Resting CD4+ T Cells In Vivo

    Tara L. Kieffer;Patty Kwon;Richard E. Nettles;Yefei Han

  • Cross-Genotype Immunity to Hepatitis C Virus

    Robert E. Lanford;Bernadette Guerra;Deborah Chavez;Catherine Bigger

Frequent Co-Authors

David L. Thomas
David L. Thomas Johns Hopkins University
Andrea L. Cox
Andrea L. Cox Johns Hopkins University School of Medicine
Thomas C. Quinn
Thomas C. Quinn Johns Hopkins University
Oliver Laeyendecker
Oliver Laeyendecker Johns Hopkins University
Robert F. Siliciano
Robert F. Siliciano Johns Hopkins University School of Medicine
Shruti H. Mehta
Shruti H. Mehta Johns Hopkins University
Joel N. Blankson
Joel N. Blankson Johns Hopkins University School of Medicine
Jacquie Astemborski
Jacquie Astemborski Johns Hopkins University
David Vlahov
David Vlahov Yale University
James E. Crowe
James E. Crowe Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring Immunology in the USA, diversifying your education with related healthcare degrees can open numerous career opportunities. Nursing programs often complement an immunology background, especially for roles in clinical research or patient care. Many students consider accelerated FNP programs, which provide a fast track to becoming a Family Nurse Practitioner, allowing professionals to work closely with immunology-related cases.

If you’re coming from a non-nursing background, online nursing programs for non nurses offer a convenient way to enter the nursing field. These programs help bridge the gap between immunology research and practical healthcare delivery.

Additionally, if you aim to complete your Bachelor of Science in Nursing more quickly, exploring accelerated nursing programs can be a smart choice. These courses typically have streamlined admission processes and intensive curricula to get graduates into the workforce faster.

For those just starting out or looking for entry-level roles, considering LPN programs with easiest admission requirements can provide practical nursing skills with relatively accessible enrollment. This foundation can support further immunology-related career growth over time.

Best Scientists Citing Stuart C. Ray

Trending Scientists